MedPath

A Clinical trial to study the efficacy of blood derived material in treating patients with ear drum perforation.

Not yet recruiting
Conditions
Chronic Suppurative Otitis Media - Tubo Tympanic Disease(Inactive)
Registration Number
CTRI/2017/04/008315
Lead Sponsor
Dr Nikhil Vallathukaran Mathew
Brief Summary

This study is a randomised, single blinded, parallel group, single centre trial comparing the improved outcome with the use of platelet rich fibrin in Tympanoplasty ear surgery as compared with conventional technique without using the platelet rich fibrin.This study will be done for 15 month over 60 patients with chronic suppurative otitis media(Inactive) with no comorbidities. The primary outcome will measure the graft take up at 1st week, 1st month and 3rd month. The healing rate of of perforation and hearing improvement post tympanoplasty is also assessed at 3rd months.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Chronic Suppurative Otiti Media- Tubotympanic Disease(Inactive).

Exclusion Criteria

Comorbities like Diabetes Mellitus, Hypertension, Bronchial Asthma, Tuberculosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess to graft uptake following application of platelet rich fibrin.At end of 1 week, 1 month and 3rd month
Secondary Outcome Measures
NameTimeMethod
To assess the rate of healing.At end of 1 week,1 month and 3 month
To assess the hearing improvement post tympanoplastyAt end of 3 months

Trial Locations

Locations (1)

ENT department, 4th Floor,New OPD Block

🇮🇳

Udupi, KARNATAKA, India

ENT department, 4th Floor,New OPD Block
🇮🇳Udupi, KARNATAKA, India
Dr Nikhil Vallathukaran Mathew
Principal investigator
8147983039
nikhilvmathew91@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.